(Q74458832)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Inflammation and atrophy in multiple sclerosis: MRI associations with disease course (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

X Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L D Blumhardt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

10 November 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

99-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Axonal transection in the lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Axonal damage in acute multiple sclerosis lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Short-term ventricular volume changes on serial MRI in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Spinal cord atrophy and disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Spinal cord atrophy and disability in MS: A longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Relapses and progression of disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

The efficiency of systematic sampling in stereology and its prediction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Automatic analysis of cerebral atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Statistical methods for assessing agreement between two methods of clinical measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

From enhancing lesions to brain atrophy in relapsing MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900576-7

10.1016/S0022-510X(01)00576-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535239%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference